Isbn: 9780323754989 - cancer immunotherapy in urology, an issue of urologic clinics: an issue of urologic clinics (4) (11 risultati)

Hardcover. Condizione: Very Good. It's a well-cared-for item that has seen limited use. The item may show minor signs of wear. All the text is legible, with all pages included. It may have slight markings and/or highlighting.

Hardcover. Condizione: Brand New. 240 pages. 10.32x7.28x0.47 inches. In Stock.

Hardback. Condizione: New. New copy - Usually dispatched within 4 working days.

Hardcover. Condizione: new. Hardcover. Cancer Immunotherapy in Urology, An Issue of Urologic Clinics Shipping may be from multiple locations in the US or from the UK, depending on stock availability.

Condizione: New. 2020. hardcover. . . . . .

Condizione: New. The Guest Editors of this issue of Urologic Clinics of North America have put together a comprehensive collection of articles that provides the current knowledge on urologic cancer immunotherapy. Expert authors have contributed clinical review articles on t.

Hardcover. Condizione: Brand New. 240 pages. 10.32x7.28x0.47 inches. In Stock.

Condizione: New. 2020. hardcover. . . . . . Books ship from the US and Ireland.

Hardcover. Condizione: new. Hardcover. Cancer Immunotherapy in Urology, An Issue of Urologic Clinics Shipping may be from our Sydney, NSW warehouse or from our UK or US warehouse, depending on stock availability.

Buch. Condizione: Neu. Neuware - The Guest Editors of this issue of Urologic Clinics of North America have put together a comprehensive collection of articles that provides the current knowledge on urologic cancer immunotherapy. Expert authors have contributed clinical review articles on the following topics: Era of personalized vaccines for GU cancers; TCR and dendritic vaccine platforms for GU cancers; Neo-adjuvant platforms for GU cancer immunotherapy; Immune-editing in Cancer: Role of tumor microenvironment and immune-suppressive pathways in localized and aggressive disease; Clinical integration of neo-adjuvant platforms for prostate cancer immunotherapy; Immunotherapy for muscle and non-muscle invasive bladder cancer: BCG and beyond; Immunotherapy for metastatic bladder cancer; Immunotherapy options for metastatic castrate-resistant prostate cancer; Role of tissue infiltrating lymphocytes: Understanding TCR; Therapeutic platforms for IPSC-derived CAR-T; Immune-suppression in prostate cancer: Underlying causes and influence on response to immunotherapy; and Racial disparity in response to immunotherapy. Urologists will come away with the most current information they need to improve outcomes in the urologic cancer patient.…

Condizione: new. Questo è un articolo print on demand.